Australian general practitioners’ perceptions of the barriers and opportunities for community-based care of patients with viral hepatitis: a mixed methods study
Belaynew Taye
1 2 3 4 * , Patricia Valery 1 3 , Burglind Liddle 5 , Aidan Woodward 1 6 7 , Shaouli Shahid 8 , Rebecca Farley 9 10 , Donata Sackey 9 11 , Paul Clark 1 2 6 7
1 Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia.
2 Mater Research Institute-UQ, Brisbane, Qld, Australia.
3 Cancer and Chronic Disease Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia.
4 Department of Epidemiology, Bahir Dar University, Bahir Dar, Ethiopia.
5 Department of Gastroenterology and Hepatology, Mater Health Services, Brisbane, Qld, Australia.
6 Department of Gastroenterology and Hepatology, Mater Hospitals, Brisbane, Qld, Australia.
7 Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Qld, Australia.
8 Centre for Aboriginal Studies, Curtin University, Bentley, WA, Australia.
9 Mater Refugee Complex Care Clinic, Brisbane, Qld, Australia.
10 Clinical Training Department, Princess Alexandra Hospital, Brisbane, Qld, Australia.
11 Refugee Health Partnership Advisory Group Qld, Brisbane, Qld, Australia.
Journal of Primary Health Care 14(3) 229-236 https://doi.org/10.1071/HC22005
Published: 21 July 2022
© 2022 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of The Royal New Zealand College of General Practitioners. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)
Abstract
Introduction: Engagement of general practitioners (GPs) is essential to improving rates of diagnosis and treatment of viral hepatitis, as traditional tertiary hospital-based models of care often face challenges.
Aim: We investigated Australian general practitioners’ perceptions of a community-based model of care for patients with viral hepatitis.
Methods: We conducted a mixed methods study using survey questionnaires (23 GPs) and an open-ended interview guide (10 GPs) at primary care clinics in Brisbane, Queensland, Australia. Quantitative data were analysed using descriptive statistics in Stata 15.1 and qualitative data were analysed using thematic analysis following an inductive approach.
Results: Patient loss to follow up and high cost of diagnostic tests were identified as the biggest challenges to providing care for patients with viral hepatitis. Most GPs interviewed believe a more community-based model of care with support to GPs may improve uptake of care and increase both GP and patient engagement. General practitioners felt a community-based model of care could also improve viral hepatitis testing and follow-up rates.
Discussion: For Australian GPs, improving patient retention and diagnostics access were key pressure points in the viral hepatitis care pathway. A broader and more profound capacity-building allows community-based viral hepatitis care to be sustainable.
Keywords: access to healthcare, culturally and linguistically diverse populations, engagement of primary care, general practitioners, mixed methods, models of care, primary health care, shared model of care, viral hepatitis.
References
[1] Yang Y, Yan M, Yue M, et al. Prevalence of hepatitis B and knowledge about hepatitis B among migrant workers in shandong province, china: a cross-sectional study. Iran Red Crescent Med J 2015; 17 e26725| Prevalence of hepatitis B and knowledge about hepatitis B among migrant workers in shandong province, china: a cross-sectional study.Crossref | GoogleScholarGoogle Scholar |
[2] Australian Bureau of Statistics. Migration, Australia, 2017-18. Canberra: Australian Bureau of Statistics; 2019.
[3] Falla AM, Veldhuijzen IK, Ahmad AA, et al. Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries. Eur J Public Health 2017; 27 302–6.
| Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries.Crossref | GoogleScholarGoogle Scholar |
[4] Clark PJ, Stuart KA, Leggett BA, et al. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia. Liver Int 2015; 35 2584–94.
| Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.Crossref | GoogleScholarGoogle Scholar |
[5] Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine. Geographic diversity in chronic hepatitis B and C prevalence, management and treatment. National report 2017. Darlinghurst, NSW: Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine; 2019.
[6] Department of Health. Third National Hepatitis B Strategy 2018–2022. Canberra: Australian Government, Department of Health; 2018.
[7] Department of Health. Fifth National Hepatitis C Strategy 2018–2022. Canberra: Australian Government Department of Health; 2018.
[8] El-Atem N, Irvine KM, Valery PC, et al. Identifying areas of need relative to liver disease: geographic clustering within a health service district. Aust Health Rev 2017; 41 407–18.
| Identifying areas of need relative to liver disease: geographic clustering within a health service district.Crossref | GoogleScholarGoogle Scholar |
[9] Wallace J, Richmond J, Allard N, et al. Facilitating hepatitis B clinical management in general practice: a qualitative investigation. Aust J Gen Pract 2020; 49 599–604.
| Facilitating hepatitis B clinical management in general practice: a qualitative investigation.Crossref | GoogleScholarGoogle Scholar |
[10] Lubel JS, Strasser SI, Thompson AJ, et al. Australian consensus recommendations for the management of hepatitis B. Med J Aust 2022; 216 478–86.
| Australian consensus recommendations for the management of hepatitis B.Crossref | GoogleScholarGoogle Scholar |
[11] Hepatitis C Virus Infection Consensus Statement Working Group. Australian recommendations for the management of hepatitis C virus infection: a consensus statement (September 2018). Melbourne: Gastroenterological Society of Australia; 2018.
[12] Clark PJ, Muir AJ. Overcoming barriers to care for hepatitis C. N Engl J Med 2012; 366 2436–8.
| Overcoming barriers to care for hepatitis C.Crossref | GoogleScholarGoogle Scholar |
[13] Strasser SI. Managing hepatitis C in general practice. Aust Prescr 2017; 40 64–9.
| Managing hepatitis C in general practice.Crossref | GoogleScholarGoogle Scholar |
[14] Lakhan P, Askew D, Hayman N, et al. Optimising hepatitis C care in an urban Aboriginal and Torres Strait Islander primary health care clinic. Aust N Z J Public Health 2019; 43 228–35.
| Optimising hepatitis C care in an urban Aboriginal and Torres Strait Islander primary health care clinic.Crossref | GoogleScholarGoogle Scholar |
[15] Clark PJ, Liddle B, Woodward A, et al. 2018. Hepatitis Research Education and Clinical Outreach (HEPREACH). Mater Research Institute, Brisbane, Australia
[16] Schoonenboom J, Johnson RB. How to construct a mixed methods research design. Kolner Z Soz Sozpsychol 2017; 69 107–31.
| How to construct a mixed methods research design.Crossref | GoogleScholarGoogle Scholar |
[17] Walter M. The Nature of Social Science Research. In: Walter M, editor. Social Research Methods. Australia: Oxford University Press; 2019. pp. 3–24.
[18] Mertens DM, Hesse-Biber S. Triangulation and mixed methods research: provocative positions. J Mix Methods Res 2012; 6 75–9.
| Triangulation and mixed methods research: provocative positions.Crossref | GoogleScholarGoogle Scholar |
[19] Primary Health Networks (PHN). Practice Incentives Program Data. Primary Health Networks (PHN); 2018. Available at https://www1.health.gov.au/internet/main/publishing.nsf/Content/PHN-PIP_Data [Accessed 23 October 2019]
[20] Thewes B, Rietjens JAC, van den Berg SW, et al. One way or another: The opportunities and pitfalls of self-referral and consecutive sampling as recruitment strategies for psycho-oncology intervention trials. Psychooncology 2018; 27 2056–9.
| One way or another: The opportunities and pitfalls of self-referral and consecutive sampling as recruitment strategies for psycho-oncology intervention trials.Crossref | GoogleScholarGoogle Scholar |
[21] Dodgson JE. Reflexivity in qualitative research. J Hum Lact 2019; 35 220–2.
| Reflexivity in qualitative research.Crossref | GoogleScholarGoogle Scholar |
[22] Pourmarzi D, Smirnov A, Hepworth J, et al. Elements of community-based models for treating hepatitis C virus in supporting HCV elimination in Australia: a Delphi study. Int J Health Plann Manage 2019; 34 e1247–56.
| Elements of community-based models for treating hepatitis C virus in supporting HCV elimination in Australia: a Delphi study.Crossref | GoogleScholarGoogle Scholar |
[23] Santos JRA. Cronbach’s alpha: a tool for assessing the reliability of scales. J Ext 1999; 37 1–5.
[24] Clarke V, Braun V. Teaching thematic analysis: overcoming challenges and developing strategies for effective learning. Psychologist 2013; 26 120–3.
[25] Willis K. Analysing qualitative data. In: Walter M, editor. Social Research Methods. Oxford, UK: Oxford University Press; 2019. pp. 341–64.
[26] Tuckett AG. Applying thematic analysis theory to practice: A researcher’s experience. Contemp Nurse 2005; 19 75–87.
| Applying thematic analysis theory to practice: A researcher’s experience.Crossref | GoogleScholarGoogle Scholar |
[27] Boyatzis RE. Transforming qualitative information: Thematic analysis and code development. Sage; 1998.
[28] Guirgis M, Yan K, Bu YM, et al. General practitioners’ knowledge and management of viral hepatitis in the migrant population. Intern Med J 2012; 42 497–504.
| General practitioners’ knowledge and management of viral hepatitis in the migrant population.Crossref | GoogleScholarGoogle Scholar |
[29] Richmond J, Smith E, Wallace J, et al. Hepatitis B testing and diagnosis experiences of patients and primary care professionals in Australia. Aust Fam Physician 2017; 46 513–9.
[30] Ringberg U, Fleten N, Førde OH. Examining the variation in GPs’ referral practice: a cross-sectional study of GPs’ reasons for referral. Br J Gen Pract 2014; 64 e426–33.
| Examining the variation in GPs’ referral practice: a cross-sectional study of GPs’ reasons for referral.Crossref | GoogleScholarGoogle Scholar |
[31] Rosemann T, Wensing M, Rueter G, et al. Referrals from general practice to consultants in Germany: if the GP is the initiator, patients’ experiences are more positive. BMC Health Serv Res 2006; 6 5
| Referrals from general practice to consultants in Germany: if the GP is the initiator, patients’ experiences are more positive.Crossref | GoogleScholarGoogle Scholar |
[32] Mitchell GK, Burridge L, Zhang J, et al. Systematic review of integrated models of health care delivered at the primary-secondary interface: how effective is it and what determines effectiveness? Aust J Prim Health 2015; 21 391–408.
| Systematic review of integrated models of health care delivered at the primary-secondary interface: how effective is it and what determines effectiveness?Crossref | GoogleScholarGoogle Scholar |
[33] Sackey D, Jones M, Farley R. Reconceptualising specialisation: integrating refugee health in primary care. Aust J Prim Health 2020; 26 452–7.
| Reconceptualising specialisation: integrating refugee health in primary care.Crossref | GoogleScholarGoogle Scholar |
[34] Hopwood M, Treloar C. Barriers to, and enablers of, embedding the management and care of viral hepatitis in primary care settings. Sydney: Centre for Social Research in Health, UNSW Australia; 2015.
[35] New Zealand Ministry of Health. Hepatitis C. Work in progress for improving hepatitis prevention and treatment services in New Zealand. Ministry of Health; 2021.
[36] McGeoch G, McGeoch P, Shand B. Is HealthPathways effective? An online survey of hospital clinicians, general practitioners and practice nurses. N Z Med J 2015; 128 36–46.
[37] New Zealand Ministry of Health. Guidance to support the implementation of regional services to deliver identification and treatment for people at risk of or with hepatitis C. Wellington: Ministry of Health; 2019.
[38] Stedman CAM, Gane EJ. New Zealand Hepatitis C Guideline for Antiviral Treatment of People who have Cirrhosis and/or are HCV Treatment-Experienced (Secondary Care Guideline). Wellington: Ministry of Health; 2019.
